Detection and Identification of Fungal Pathogens by Multiplex PCR in Pulmonary Tuberculosis Patients in Kancheepuram
Schlagwörter:
Aspergillus, Tuberculosis, multiplex PCR, rapidAbstract
Tuberculosis is a common infection in developing countries. Pulmonary tuberculosis is the most commonly associated disease in cases of secondary aspergilloma. Fungus infection is gradually becoming commoner and has been difficult to evaluate since diagnoses were seldom confirmed. Multiplex PCR method provides a rapid, simple, and reliable alternative to conventional methods to identify common clinical fungal isolates. Hence, this study was taken up to find the fungal co-infections among TB patients and also to confirm the isolates by multiplex PCR. Sputum samples were collected from 80 patients who were TB-positive and were on ATT from MMCH&RI between Feb 2012 and Dec 2012. Samples were processed and identified as per standard protocol. Growth was confirmed by repeated isolation for at least 3 times. Out of 80 pulmonary tuberculosis-positive patients, 26 cultures grew fungus, 12 were found to be Aspergillus sp. three Candida albicans, four Mucor, four Fusarium, one Cladosporium spp. and one Paecelomyces spp. was obtained from the culture. Off all the 26 isolates obtained, 12 strains of Aspergillus sp. were taken for molecular identification by multiplex PCR. Opportunistic mycoses are often grave, the early, rapid, and accurate identification of the pathogenic fungus is critical for timely and appropriate management. From this study, the authors have found correlation between fungal isolation, duration of ATT, and extent of lesion and in relation to the cavity form. It is necessary to screen all TB patients irrespective of ATT in order to start antifungal therapy.Keywords: Aspergillus, Tuberculosis, multiplex PCR, rapidVeröffentlicht
Ausgabe
Rubrik
Lizenz
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
· I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
· I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
· I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
· I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
_______________
We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |